We are live on ! Find out more
ARCK

Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock

Delisted

ARCK was delisted on the 12th of January, 2023.

52 hedge funds and large institutions have $125M invested in Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock in 2022 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 9 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,800% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 1

200% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 3

117% more funds holding

Funds holding: 2452 (+28)

111% more capital invested

Capital invested by funds: $59.1M → $125M (+$65.6M)

Holders
52
Holders Change
+28
Holders Change %
+116.67%
% of All Funds
0.82%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
29
Increased
9
Reduced
3
Closed
1
Calls
$33K
Puts
Net Calls
+$33K
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
PP
51
Paloma Partners
Connecticut
$100K
BCM
52
Basso Capital Management
Connecticut
$3K +$2.97K +297 New
FLC
53
Fifth Lane Capital
Texas
-$498K -50,000 Closed

ARCK Hedge Fund Activity: Q1 2022 in Review

52 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock (ARCK) for Q1 2022, worth a combined $125M — up 111% from $59.1M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new ARCK positions and 1 closed out — a net gain of 28 holders — while 9 added to existing stakes and 3 trimmed.

The largest buyer was MMCAP International, opening a new position worth an estimated $5.5M. The largest seller was Beryl Capital Management, cutting an estimated $3.34M.

  • 52 institutional investors held Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock (ARCK) as of Q1 2022, up from 24 in Q4 2021.
  • Funds reported $125M of Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock stock for Q1 2022, up 111% quarter-over-quarter.
  • 29 funds opened new Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock positions in Q1 2022 and 1 closed out, a net change of +28 holders.
  • The largest Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock buyer in Q1 2022 was MMCAP International, an estimated $5.5M added.
  • The largest Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock seller in Q1 2022 was Beryl Capital Management, an estimated $3.34M sold.

Based on aggregated 13F filings for Q1 2022.